256 related articles for article (PubMed ID: 31285236)
1. Revisiting the Pharmacodynamic Uroselectivity of
Quaresma BMCS; Pimenta AR; Santos da Silva AC; Pupo AS; Romeiro LAS; Silva CLM; Noël F
J Pharmacol Exp Ther; 2019 Oct; 371(1):106-112. PubMed ID: 31285236
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
3. Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
Seo KK; Lee MY; Lim SW; Kim SC
J Korean Med Sci; 1999 Feb; 14(1):69-74. PubMed ID: 10102527
[TBL] [Abstract][Full Text] [Related]
4. Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtype.
Sato S; Hatanaka T; Yuyama H; Ukai M; Noguchi Y; Ohtake A; Taguchi K; Sasamata M; Miyata K
Biol Pharm Bull; 2012; 35(1):72-7. PubMed ID: 22223340
[TBL] [Abstract][Full Text] [Related]
5. A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia.
Manjunatha R; Pundarikaksha HP; Madhusudhana HR; Amarkumar J; Hanumantharaju BK
Indian J Pharmacol; 2016; 48(2):134-40. PubMed ID: 27127315
[TBL] [Abstract][Full Text] [Related]
6. New Multi-target Antagonists of α1A-, α1D-Adrenoceptors and 5-HT1A Receptors Reduce Human Hyperplastic Prostate Cell Growth and the Increase of Intraurethral Pressure.
Nascimento-Viana JB; Carvalho AR; Nasciutti LE; Alcántara-Hernández R; Chagas-Silva F; Souza PA; Romeiro LA; García-Sáinz JA; Noël F; Silva CL
J Pharmacol Exp Ther; 2016 Jan; 356(1):212-22. PubMed ID: 26493747
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of α
Yoshizumi M; Ise SN; Yonezawa A; Watanabe C; Sakurada S; Mizoguchi H
Basic Clin Pharmacol Toxicol; 2024 May; 134(5):704-711. PubMed ID: 38409579
[TBL] [Abstract][Full Text] [Related]
8. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
[TBL] [Abstract][Full Text] [Related]
9. Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia.
Yamada S; Kato Y; Okura T; Kagawa Y; Kawabe K
Biol Pharm Bull; 2007 Jul; 30(7):1237-41. PubMed ID: 17603160
[TBL] [Abstract][Full Text] [Related]
10. Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.
Martin DJ; Lluel P; Guillot E; Coste A; Jammes D; Angel I
J Pharmacol Exp Ther; 1997 Jul; 282(1):228-35. PubMed ID: 9223558
[TBL] [Abstract][Full Text] [Related]
11. Prostatic alpha 1-adrenoceptors and uroselectivity.
Andersson KE; Lepor H; Wyllie MG
Prostate; 1997 Feb; 30(3):202-15. PubMed ID: 9122046
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes.
Richardson CD; Donatucci CF; Page SO; Wilson KH; Schwinn DA
Prostate; 1997 Sep; 33(1):55-9. PubMed ID: 9294627
[TBL] [Abstract][Full Text] [Related]
13. [Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)].
Tatemichi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N
Yakugaku Zasshi; 2006 Mar; 126 Spec no.():209-16. PubMed ID: 16518085
[TBL] [Abstract][Full Text] [Related]
14. Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.
Kobayashi S; Tomiyama Y; Maruyama K; Hoyano Y; Yamazaki Y; Kusama H
J Smooth Muscle Res; 2009 Aug; 45(4):187-95. PubMed ID: 19783871
[TBL] [Abstract][Full Text] [Related]
15. Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia.
Forray C; Noble SA
Expert Opin Investig Drugs; 1999 Dec; 8(12):2073-2094. PubMed ID: 11139841
[TBL] [Abstract][Full Text] [Related]
16. Preclinical pharmacology of alpha1-adrenoceptor antagonists.
Martin DJ
Eur Urol; 1999; 36 Suppl 1():35-41; discussion 65. PubMed ID: 10393471
[TBL] [Abstract][Full Text] [Related]
17. Alpha
Britto-Júnior J; Guimarães RAB; Oliveira DL; Lima AT; Quirino Junior G; de Oliveira Stocco GA; Salgado Uramoto EH; Fregonesi A; Antunes E; De Nucci G
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3227-3238. PubMed ID: 37910185
[TBL] [Abstract][Full Text] [Related]
18. Is Tamsulosin Linked to Dementia in the Elderly?
Frankel JK; Duan Y; Albertsen PC
Curr Urol Rep; 2018 Jul; 19(9):69. PubMed ID: 29971698
[TBL] [Abstract][Full Text] [Related]
19. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
Kyprianou N; Chon J; Benning CM
Prostate Suppl; 2000; 9():42-6. PubMed ID: 11056502
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
Kojima Y; Sasaki S; Kubota Y; Imura M; Oda N; Kiniwa M; Hayashi Y; Kohri K
J Urol; 2011 Oct; 186(4):1530-6. PubMed ID: 21855934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
